Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

ExoTherapy offers hope for treating acute spinal cord injuries

Suffering from traumatic injuries can leave a person with long-term damages and/or side effects that are hard to navigate long after the initial incident has passed. Our next company is a publicly traded bio-pharmaceutical company, working on the development of its ...
Brieanna McCutcheon | September 19, 2023 |

Baudax Shares Rise as FDA Approves NDA for Its Non-Opioid Pain Medication

Shares of Baudax Bio traded more than 20% higher and set a new 52-week high price after reporting that the FDA approved the company's non-opioid ANJESO™ drug for management of moderate to severe pain. Specialty pharmaceutical company Baudax Bio Inc. (BXRX:N...
Streetwise Reports | February 24, 2020 |

April 1st 2020, Crypto Chartbook: You snooze you lose

You snooze you lose The required skill level to prosper trading is treading light footed. This is only possible with confidence. Confidence comes from a knowing. Knowing settles in after a long time of experience. However any professional can get shaken up, hence the sayi...
Korbinian Koller | April 1, 2020 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

Buzz on the Bullboards: the HIDDEN Cannabis Market

After 100 years of cannabis Prohibition, perhaps we shouldn’t be surprised that the normalization of cannabis laws in North America (and around the world) has been a slow, uneven process. Even so, cannabis investors will likely be surprised to learn how clumsy ...
Stockhouse Editorial | March 15, 2019 |

Core Inflation Rises but Fed Is Going to Cut Rates. Will Gold Gain?

The combination doesn’t feel right. Actually, something stinks – just what is it exactly? Payrolls were strong, while core inflation rose. Nevertheless, the Fed signaled it’s going to cut interest rate. Our shiny yellow friend, can you help us m...
Arkadiusz Sieron | July 16, 2019 |

X-Terra Resources: The Undiscovered Discovery

Investor Riley Ireland provides his investment thesis for this explorer with gold properties in Canada. X-Terra's Grog Property Investment Highlights: Strong management with direct ownership Low market cap of $4,709,629 New gold di...
Streetwise Reports | June 2, 2020 |

How to Navigate These Tricky Waters of the Stock Bull Market

Stocks keep reaching for new highs, but the bearish wedge and volume are giving me second thoughts. Stocks are getting ready to move, and today's analysis will paint as clear a picture thereof as it gets. S&P 500 in the Short-Run Let’s start with the dail...
Monica Kingsley | June 4, 2020 |

Reaping the Early Benefits of Inflation in Stocks

Something big to move stocks is brewing under the surface – Treasuries are down, the dollar is under pressure, gold refusing to decline much… I think it's the market's growing realization that all the post-corona money printing, stimulus bills, will be hugely inflationary, and...
Monica Kingsley | June 5, 2020 |

Cracking the Code to Society’s Most Feared Disease

Even more so than cancer, it’s the one disease that we all fear the most. The thought of falling prey to Alzheimer’s disease and to the inevitable desecration of our mind is something that makes even the bravest among us shudder. ...
Marc Davis | February 7, 2020 |
1 2 3 4 5 6